Epigenomics and Cancer Risk Factors, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Epigenomics and Cancer Risk Factors, German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Semin Cancer Biol. 2018 Aug;51:12-21. doi: 10.1016/j.semcancer.2018.01.010. Epub 2018 Jan 31.
Analogous to life on earth, tumor cells evolve through space and time and adapt to different micro-environmental conditions. As a result, tumors are composed of millions of genetically diversified cells at the time of diagnosis. Profiling these variants contributes to understanding tumors' clonal origins and might help to better understand response to therapy. However, even genetically homogenous cell populations show remarkable diversity in their response to different environmental stimuli, suggesting that genetic heterogeneity does not explain the full spectrum of tumor plasticity. Understanding epigenetic diversity across cancer cells provides important additional information about the functional state of subclones and therefore allows better understanding of tumor evolution and resistance to current therapies.
与地球上的生命类似,肿瘤细胞会随着时间和空间的变化而进化,并适应不同的微环境条件。因此,在诊断时,肿瘤由数百万个遗传上多样化的细胞组成。对这些变体进行分析有助于了解肿瘤的克隆起源,并可能有助于更好地了解对治疗的反应。然而,即使遗传上同质的细胞群体在对不同环境刺激的反应中也表现出显著的多样性,这表明遗传异质性并不能解释肿瘤可塑性的全貌。了解癌细胞中的表观遗传多样性提供了关于亚克隆功能状态的重要附加信息,因此可以更好地理解肿瘤的进化和对当前治疗方法的耐药性。